Semba Charles Pauling's Form 4 filing
DiaMedica Therapeutics Inc. (DMAC) · filed Jun 26, 2023
- Accession no.
- 0001235802-23-000071
- Filed
- Jun 26, 2023
- Trade date
- Jun 23, 2023
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $50.0K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Semba Charles PaulingCIK 0001872863 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 23, 2023 | Voting Common Shares, no par value per share | PPurchaseAcquired | +12,787 | $3.91 | +$49,997.17 | 29,943 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.